COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Shuai Xia
Institution
Fudan University
Address
Shanghai
China
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2010
1
2011
1
2014
3
2015
4
2016
1
2017
4
2018
10
2019
7
2020
14
2021
6
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Hua C
,
Ma Q
,
Zhu Y
,
Xia S
,
Liu Z
,
Li L
,
Lu L
,
Zhong N
,
Liu S
,
Yang Z
,
Jiang S
. Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation. Signal Transduct Target Ther. 2021 08 26; 6(1):318.
PMID:
34446694
.
Citations:
1
Translation:
Humans
Zhou J
,
Xu W
,
Liu Z
,
Wang C
,
Xia S
,
Lan Q
,
Cai Y
,
Su S
,
Pu J
,
Xing L
,
Xie Y
,
Lu L
,
Jiang S
,
Wang Q
. A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases. Acta Pharm Sin B. 2021 Aug 02.
PMID:
34367893
.
Citations:
Xia S
,
Lan Q
,
Zhu Y
,
Wang C
,
Xu W
,
Li Y
,
Wang L
,
Jiao F
,
Zhou J
,
Hua C
,
Wang Q
,
Cai X
,
Wu Y
,
Gao J
,
Liu H
,
Sun G
,
Münch J
,
Kirchhoff F
,
Yuan Z
,
Xie Y
,
Sun F
,
Jiang S
,
Lu L
. Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation. Signal Transduct Target Ther. 2021 07 29; 6(1):288.
PMID:
34326308
.
Citations:
6
Translation:
Humans
Animals
Cells
Lan Q
,
Pu J
,
Cai Y
,
Zhou J
,
Wang L
,
Jiao F
,
Xu W
,
Wang Q
,
Xia S
,
Lu L
,
Jiang S
. Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection. Microbes Infect. 2021 Sep-Oct; 23(8):104840.
PMID:
34022374
.
Citations:
Fields:
All
Allergy and Immunology
Mic
Microbiology
Translation:
Humans
Cells
Wang C
,
Xia S
,
Wang X
,
Li Y
,
Wang H
,
Xiang R
,
Jiang Q
,
Lan Q
,
Liang R
,
Li Q
,
Huo S
,
Lu L
,
Wang Q
,
Yu F
,
Liu K
,
Jiang S
. Supercoiling Structure-Based Design of a Trimeric Coiled-Coil Peptide with High Potency against HIV-1 and Human ß-Coronavirus Infection. J Med Chem. 2022 02 24; 65(4):2809-2819.
PMID:
33929200
.
Citations:
Fields:
Che
Chemistry
Wang X
,
Xia S
,
Zhu Y
,
Lu L
,
Jiang S
. Pan-coronavirus fusion inhibitors as the hope for today and tomorrow. Protein Cell. 2021 02; 12(2):84-88.
PMID:
33420956
.
Citations:
6
Fields:
Bio
Biochemistry
Cel
Cell Biology
Translation:
Humans
Cells
Liu P
,
Cai J
,
Jia R
,
Xia S
,
Wang X
,
Cao L
,
Zeng M
,
Xu J
. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19. Emerg Microbes Infect. 2020 Dec; 9(1):1254-1258.
PMID:
32515685
.
Citations:
22
Fields:
Com
Communicable Diseases
Translation:
Humans
Cells
PH
Public Health
Liu Z
,
Xu W
,
Xia S
,
Gu C
,
Wang X
,
Wang Q
,
Zhou J
,
Wu Y
,
Cai X
,
Qu D
,
Ying T
,
Xie Y
,
Lu L
,
Yuan Z
,
Jiang S
. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target Ther. 2020 11 27; 5(1):282.
PMID:
33247109
.
Citations:
34
Translation:
Humans
Animals
Cells
PH
Public Health
Rao L
,
Xia S
,
Xu W
,
Tian R
,
Yu G
,
Gu C
,
Pan P
,
Meng QF
,
Cai X
,
Qu D
,
Lu L
,
Xie Y
,
Jiang S
,
Chen X
. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc Natl Acad Sci U S A. 2020 11 03; 117(44):27141-27147.
PMID:
33024017
.
Citations:
43
Fields:
Sci
Science
Translation:
Humans
Animals
Cells
PH
Public Health
Wu F
,
Liu M
,
Wang A
,
Lu L
,
Wang Q
,
Gu C
,
Chen J
,
Wu Y
,
Xia S
,
Ling Y
,
Zhang Y
,
Xun J
,
Zhang R
,
Xie Y
,
Jiang S
,
Zhu T
,
Lu H
,
Wen Y
,
Huang J
. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China. JAMA Intern Med. 2020 10 01; 180(10):1356-1362.
PMID:
32808970
.
Citations:
85
Fields:
Int
Internal Medicine
Translation:
Humans
Cells
PH
Public Health
Wang X
,
Xu W
,
Hu G
,
Xia S
,
Sun Z
,
Liu Z
,
Xie Y
,
Zhang R
,
Jiang S
,
Lu L
. Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol. 2020 08; 17(8):894.
PMID:
32651469
.
Citations:
17
Fields:
All
Allergy and Immunology
Xia S
,
Lan Q
,
Su S
,
Wang X
,
Xu W
,
Liu Z
,
Zhu Y
,
Wang Q
,
Lu L
,
Jiang S
. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin. Signal Transduct Target Ther. 2020 06 12; 5(1):92.
PMID:
32532959
.
Citations:
91
Translation:
Humans
Cells
Wang X
,
Xia S
,
Wang Q
,
Xu W
,
Li W
,
Lu L
,
Jiang S
. Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases. Int J Mol Sci. 2020 May 28; 21(11).
PMID:
32481690
.
Citations:
17
Fields:
Bio
Biochemistry
Che
Chemistry
Mol
Molecular Biology
Translation:
Humans
Animals
Cells
Wu Y
,
Li C
,
Xia S
,
Tian X
,
Kong Y
,
Wang Z
,
Gu C
,
Zhang R
,
Tu C
,
Xie Y
,
Yang Z
,
Lu L
,
Jiang S
,
Ying T
. Identification of Human Single-Domain Antibodies against SARS-CoV-2. Cell Host Microbe. 2020 06 10; 27(6):891-898.e5.
PMID:
32413276
.
Citations:
89
Fields:
Mic
Microbiology
Translation:
Humans
Cells
Wang X
,
Xu W
,
Hu G
,
Xia S
,
Sun Z
,
Liu Z
,
Xie Y
,
Zhang R
,
Jiang S
,
Lu L
. RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol. 2020 04 07.
PMID:
32265513
.
Citations:
105
Fields:
All
Allergy and Immunology
Liu Z
,
Xia S
,
Wang X
,
Lan Q
,
Xu W
,
Wang Q
,
Jiang S
,
Lu L
. Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection. Virol Sin. 2020 06; 35(3):340-343.
PMID:
32236815
.
Citations:
6
Fields:
Vir
Virology
Translation:
Humans
Animals
Cells
PH
Public Health
Xia S
,
Liu M
,
Wang C
,
Xu W
,
Lan Q
,
Feng S
,
Qi F
,
Bao L
,
Du L
,
Liu S
,
Qin C
,
Sun F
,
Shi Z
,
Zhu Y
,
Jiang S
,
Lu L
. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020 Apr; 30(4):343-355.
PMID:
32231345
.
Citations:
417
Fields:
Cel
Cell Biology
Translation:
Humans
Animals
Cells
PH
Public Health
Tian X
,
Li C
,
Huang A
,
Xia S
,
Lu S
,
Shi Z
,
Lu L
,
Jiang S
,
Yang Z
,
Wu Y
,
Ying T
. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 2020; 9(1):382-385.
PMID:
32065055
.
Citations:
534
Fields:
Com
Communicable Diseases
Translation:
Humans
Cells
Xia S
,
Zhu Y
,
Liu M
,
Lan Q
,
Xu W
,
Wu Y
,
Ying T
,
Liu S
,
Shi Z
,
Jiang S
,
Lu L
. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. 2020 07; 17(7):765-767.
PMID:
32047258
.
Citations:
201
Fields:
All
Allergy and Immunology
Translation:
Humans
Cells
PH
Public Health
Jiang S
,
Xia S
,
Ying T
,
Lu L
. A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome. Cell Mol Immunol. 2020 05; 17(5):554.
PMID:
32024976
.
Citations:
54
Fields:
All
Allergy and Immunology
Translation:
Humans
Cells
PH
Public Health
Xia S
, Yan L,
Xu W
,
Agrawal AS
,
Algaissi A
,
Tseng CK
, Wang Q,
Du L
,
Tan W
,
Wilson IA
,
Jiang S
, Yang B,
Lu L
. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci Adv. 2019 04; 5(4):eaav4580.
PMID:
30989115
.
Citations:
146
Fields:
Sci
Science
Translation:
Humans
Animals
Cells
Xia S
,
Lan Q
,
Pu J
, Wang C,
Liu Z
, Xu W,
Wang Q
, Liu H,
Jiang S
,
Lu L
. Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4. Viruses. 2019 01 14; 11(1).
PMID:
30646495
.
Citations:
11
Fields:
Vir
Virology
Translation:
Animals
Cells
Wang C,
Hua C
,
Xia S
, Li W, Lu L,
Jiang S
. Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBD. Viruses. 2019 01 06; 11(1).
PMID:
30621343
.
Citations:
8
Fields:
Vir
Virology
Translation:
Humans
Animals
Cells
Wang C, Zhao L,
Xia S
,
Zhang T
,
Cao R
, Liang G, Li Y, Meng G, Wang W, Shi W,
Zhong W
,
Jiang S
,
Liu K
. De Novo Design of a-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. J Med Chem. 2018 10 11; 61(19):8734-8745.
PMID:
30192544
.
Citations:
13
Fields:
Che
Chemistry
Translation:
Humans
Cells
Wang C,
Xia S
,
Zhang P
,
Zhang T
, Wang W, Tian Y, Meng G,
Jiang S
,
Liu K
. Discovery of Hydrocarbon-Stapled Short a-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. J Med Chem. 2018 03 08; 61(5):2018-2026.
PMID:
29442512
.
Citations:
16
Fields:
Che
Chemistry
Translation:
Humans
Cells
Xia S
, Xu W,
Wang Q
, Wang C,
Hua C
, Li W,
Lu L
,
Jiang S
. Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains. Int J Mol Sci. 2018 Feb 06; 19(2).
PMID:
29415501
.
Citations:
24
Fields:
Bio
Biochemistry
Che
Chemistry
Mol
Molecular Biology
Translation:
Humans
Animals
Cells
Su S
, Zhu Y,
Ye S
, Qi Q,
Xia S
, Ma Z,
Yu F
,
Wang Q
,
Zhang R
,
Jiang S
,
Lu L
. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors. J Virol. 2017 Jan 01; 91(1).
PMID:
27795416
.
Citations:
13
Fields:
Vir
Virology
Translation:
Humans
Cells
Xia S
,
Wang Q
,
Liu SW
,
Lu L
,
Jiang SB
. [Development of peptidic MERS-CoV entry inhibitors]. Yao Xue Xue Bao. 2015 Dec; 50(12):1513-9.
PMID:
27169270
.
Citations:
2
Fields:
Pha
Pharmacology
Pha
Pharmacy
Translation:
Humans
Cells
Lu L
,
Xia S
,
Ying T
,
Jiang S
. Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS). Emerg Microbes Infect. 2015 Jun 17; 4:e37.
PMID:
26954884
.
Citations:
6
Fields:
Com
Communicable Diseases
Translation:
Humans
Cells
Channappanavar R
,
Lu L
,
Xia S
,
Du L
,
Meyerholz DK
,
Perlman S
,
Jiang S
. Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection. J Infect Dis. 2015 Dec 15; 212(12):1894-903.
PMID:
26164863
.
Citations:
46
Fields:
Com
Communicable Diseases
Translation:
Humans
Animals
Cells
Liu Q,
Xia S
, Sun Z,
Wang Q
,
Du L
,
Lu L
,
Jiang S
. Testing of Middle East respiratory syndrome coronavirus replication inhibitors for the ability to block viral entry. Antimicrob Agents Chemother. 2015 Jan; 59(1):742-4.
PMID:
25331705
.
Citations:
23
Fields:
Ant
Anti-Infective Agents
Translation:
Humans
Cells
Xia S
, Liu Q,
Wang Q
, Sun Z,
Su S
,
Du L
,
Ying T
,
Lu L
,
Jiang S
. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Res. 2014 Dec 19; 194:200-10.
PMID:
25451066
.
Citations:
46
Fields:
Vir
Virology
Translation:
Humans
Cells
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs
Xia's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (186)
Derived automatically from this person's publications.
Viral Fusion Protein Inhibitors
Virus Internalization
Protein Interaction Domains and Motifs
Viral Fusion Proteins
Membrane Fusion
Explore
_
Co-Authors (155)
People in Profiles who have published with this person.
Jiang, Shibo
Lu, Lu
Lan, Qiaoshuai
Wang, Xinling
Ying, Tianlei
Explore
_
Similar People (60)
People who share similar concepts with this person.
Jiang, Shibo
Lu, Lu
Yuen, Kwok-Yung
Baric, Ralph
Bosch, Berend-Jan
Explore
_